tirzepatide glucagon Beyond glycemia: Comparing to GLP-1 analogues | Reviews in Endocrine and Metabolic Disorders Putative mechanism(s) of action of

Several clinical scenarios warrant discussion: You should consider speaking with your GP if: You have type 2 diabetes that is inadequately controlled despite lifestyle modifications and metformin therapy, and your HbA1c remains above target You are struggling with weight management despite optimised thyroid hormone replacement, and you might meet NICE criteria for medical weight management (typically requiring referral to specialist weight management services) You have cardiovascular disease alongside type 2 diabetes, as some GLP-1 agonists (semaglutide, liraglutide, dulaglutide) have demonstrated cardiovascular benefits Your current diabetes medications are causing problematic side effects or hypoglycaemia Before your appointment , it is helpful to: Ensure your thyroid function has been checked recently (within the past 6 months) Compile a list of all current medications, including levothyroxine dose and timing Document your weight history and any previous weight management attempts Note any family history of thyroid cancer or endocrine conditions Prepare questions about potential benefits, risks, and alternatives Your GP will assess your suitability for GLP-1 therapy by reviewing your medical history, current thyroid status, diabetes control (if applicable), and overall health

Individual responses to investigational therapies vary and depend on multiple clinical factors

The real importance is the gain in health

Pharmacy Simple Online Healthcare told Metro more than 60,000 customers registered their interest in the oral GLP-1 treatment in less than 24 hours, while Superdrug Online Doctor saw a 130% increase in people registering their interest in the same time frame

How to maximize your early results on semaglutide While the medication does the heavy lifting for appetite control, several evidence-based strategies can amplify your early results and help you notice benefits sooner